We believe in better

We believe medical tests – whether for allergies or disease detection – can be conducted when and where they’re needed. We believe accurate testing can be done quickly, conveniently and less invasively, to improve both the patient and physician experience.

So we’re doing it.

Our values

Kenota
Passionate

We’re focused on the end game and drive hard to create change for the better

Kenota
Exacting

We expect a lot from ourselves: we know the accuracy, quality and safety of our product are paramount

Kenota
Innovative

We think differently: we challenge assumptions and explore new approaches to solve human problems

Kenota
Accountable

We’re focused on delivering great results for our customers and their patients, for our investors and each other

Kenota
Team Players

We share the wins and view success as a collective pursuit

Kenota
Decisive

We take smart risks and make tough decisions to keep moving the dial

Our leadership team

Moufeed Kaddoura
Founder & CEO

Scientist, Serial entrepreneur Forbes 30under30 – Healthcare

Moufeed Kaddoura
Founder & CEO
Total IgE:
177
Allergies:
Timothy grass, bermuda grass, blue grass, ragweed
Chris Harder, PhD
CTO

Developed 4 diagnostics platforms (device, collection kits and tests) in 13 years. Products approved by FDA, HC, EU, Korea, Singapore and MENA

Chris Harder, PhD
CTO
Total IgE:
1300
Allergies:
Seasonal (ragweed, trees, pollens) and many foods
Bruce Brown
Vice President, Marketing

20 years leading global marketing efforts for global medtech companies, both large international and smaller startup organizations

Bruce Brown
Vice President, Marketing
Total IgE:
150
Allergies:
Horse dander, pollen
Meda Costea, CPA, CMA
Director, Finance & Admin

15+ years of experience in building, improving and leading finance and commercial streams in complex organizations

Meda Costea CPA CMA
Director, Finance & Admin
Total IgE:
25
Allergies:
None diagnosed
Geeta Bhat, MD
Director, Clinical & Analytical

20 years of experience developing tests and running clinical studies. Several tests approved by FDA and HC

Geeta Bhat, MD
Director, Clinical & Analytical
Total IgE:
67
Allergies:
None diagnosed
Martin Mann, MBA
Director, Regulatory

15+ years of regulatory affairs experience at Phadia, the inventors of the world-leading ImmunoCAP IgE blood tests.

Martin Mann, MBA
Director, Regulatory
Total IgE:
20
Allergies:
None diagnosed
Mona Lisa
Director, Morale

Board of Directors

Ruth Abdulmassih
Ruth is the CEO of Path-Tec, a leading provider of specimen collection kits and components. Prior to joining Path-Tec, she held multiple leadership positions at various laboratory and regulated businesses, including 23 years with Abbott. Ruth is a corporate strategist and an experienced business leader.
Dennis Flannelly
Dennis is the Head of Precision Medicine for US Oncology at Merck. Prior to joining Merck, he served as the Vice President and General Manager of Immunodiagnostics at PerkinElmer. Dennis has also served as Global Head of Clinical Marketing for Thermo Fisher Scientific's immunodiagnostics business.
Conrad Seaman
Conrad is the Principal at VeraMito Inc., an investor in Kenota. He brings 15+ years of experience in technology licensing, product management and business development, along with an expertise in banking, software, mobile devices, IoT/IIoT, automotive and manufacturing.

Our investors